1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Customer Service: 800.544.0155
All Contents © 2019The Kiplinger Washington Editors
This is the time of year when stocks are sleepy at best, and at worst, prone to pullbacks.
That’s not necessarily true of all equities, however. Some groups are very active and perform quite...
Cancer. The mere mention of the word can drudge up discomfort, as most everyone knows it’s second only to heart disease when it comes to claiming lives. Unlike heart disease, though, cancer is difficult...
When investors think of biotech stocks, visions of Amgen (AMGN) and Gilead (
More Investing News »